Gizem Akçakoca

Gizem Akçakoca

Auto-generated profile, based on publicly available information

Gizem Akçakoca

Istanbul Kartal Dr. Lutfi Kırdar City Hospital, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
GAGizem Akçakoca
Gizem Akçakoca
YTYasin Tosun
Yasin Tosun
EMEcem Memişoğlu
Ecem Memişoğlu
ÖİÖmer Faruk İnanç
Ömer Faruk İnanç
CHCemal Hacıalioğlu
Cemal Hacıalioğlu
HKHasan Fehmi Küçük
Hasan Fehmi Küçük
SUMMARY OBJECTIVE: The aim of the study was to examine the effectiveness of adding indocyanine green fluorescence to the dual method, (Radioisotope+Isosulfanblue) for sentinel lymph node biopsy after neoadjuvant chemotherapy (on sentinel lymph nodes identification). METHODS: The 101 patients included in the study were randomized equally into each group. Dual method containing indocyanine green (group 1) or dual method alone (group 2) was used for sentinel lymph node mapping. RESULTS: The sentinel lymph node identification rate was 86.9% in the dual method group and 94.6% in the triple method group. The detection rates of two or more sentinel lymph nodes were 82.6% in the dual group and 89.2% in the triple group. There was no statistically significant difference between both the groups (p>0.05). CONCLUSION: Indocyanine green-based sentinel lymph node biopsy detection will bring a significant change in the management of patients in centers where there is no access to a nuclear medicine department. Nevertheless, multicenter studies with larger patient samples are needed to confirm our results.